Surgical Science Sweden Stock Net Income
| SUSRF Stock | USD 3.41 0.00 0.00% |
As of the 11th of February 2026, Surgical Science has the Risk Adjusted Performance of (0.09), coefficient of variation of (781.34), and Variance of 52.41. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Surgical Science Sweden, as well as the relationship between them. Please validate Surgical Science Sweden risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Surgical Science is priced more or less accurately, providing market reflects its prevalent price of 3.41 per share. Given that Surgical Science Sweden has information ratio of (0.14), we advise you to double-check Surgical Science Sweden's current market performance to make sure the company can sustain itself at a future point.
Surgical Science's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Surgical Science's valuation are provided below:Surgical Science Sweden does not presently have any fundamental trend indicators for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Surgical |
Surgical Science 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Surgical Science's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Surgical Science.
| 11/13/2025 |
| 02/11/2026 |
If you would invest 0.00 in Surgical Science on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding Surgical Science Sweden or generate 0.0% return on investment in Surgical Science over 90 days. Surgical Science is related to or competes with Vitalhub Corp, COLTENE Holding, Cogstate, BioInvent International, Knight Therapeutics, Avacta Group, and Kneat. Surgical Science Sweden AB develops and markets virtual reality simulators for evidence-based laparoscopic and endoscopi... More
Surgical Science Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Surgical Science's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Surgical Science Sweden upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 60.8 | |||
| Value At Risk | (1.42) | |||
| Potential Upside | 0.5587 |
Surgical Science Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Surgical Science's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Surgical Science's standard deviation. In reality, there are many statistical measures that can use Surgical Science historical prices to predict the future Surgical Science's volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.80) | |||
| Total Risk Alpha | (1.68) | |||
| Treynor Ratio | 0.5494 |
Surgical Science February 11, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | 0.5594 | |||
| Mean Deviation | 1.96 | |||
| Coefficient Of Variation | (781.34) | |||
| Standard Deviation | 7.24 | |||
| Variance | 52.41 | |||
| Information Ratio | (0.14) | |||
| Jensen Alpha | (0.80) | |||
| Total Risk Alpha | (1.68) | |||
| Treynor Ratio | 0.5494 | |||
| Maximum Drawdown | 60.8 | |||
| Value At Risk | (1.42) | |||
| Potential Upside | 0.5587 | |||
| Skewness | (7.88) | |||
| Kurtosis | 63.31 |
Surgical Science Sweden Backtested Returns
Surgical Science Sweden owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.14, which indicates the firm had a -0.14 % return per unit of risk over the last 3 months. Surgical Science Sweden exposes eighteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Surgical Science's Risk Adjusted Performance of (0.09), coefficient of variation of (781.34), and Variance of 52.41 to confirm the risk estimate we provide. The entity has a beta of -1.7, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Surgical Science are expected to decrease by larger amounts. On the other hand, during market turmoil, Surgical Science is expected to outperform it. At this point, Surgical Science Sweden has a negative expected return of -1.01%. Please make sure to validate Surgical Science's maximum drawdown and rate of daily change , to decide if Surgical Science Sweden performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.00 |
No correlation between past and present
Surgical Science Sweden has no correlation between past and present. Overlapping area represents the amount of predictability between Surgical Science time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Surgical Science Sweden price movement. The serial correlation of 0.0 indicates that just 0.0% of current Surgical Science price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | -0.27 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Surgical Science Sweden reported net income of 86.25 M. This is 74.73% lower than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The net income for all United States stocks is 84.89% higher than that of the company.
Surgical Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Surgical Science's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Surgical Science could also be used in its relative valuation, which is a method of valuing Surgical Science by comparing valuation metrics of similar companies.Surgical Science is currently under evaluation in net income category among its peers.
Surgical Fundamentals
| Return On Equity | 0.0357 | |||
| Return On Asset | 0.0212 | |||
| Profit Margin | 0.18 % | |||
| Current Valuation | 743.09 M | |||
| Shares Outstanding | 50.8 M | |||
| Shares Owned By Insiders | 32.75 % | |||
| Shares Owned By Institutions | 52.03 % | |||
| Price To Earning | 73.41 X | |||
| Price To Book | 2.26 X | |||
| Price To Sales | 15.43 X | |||
| Revenue | 366.78 M | |||
| Gross Profit | 265.94 M | |||
| EBITDA | 122.27 M | |||
| Net Income | 86.25 M | |||
| Total Debt | 29.42 M | |||
| Debt To Equity | 0 % | |||
| Current Ratio | 2.66 X | |||
| Cash Flow From Operations | 39.08 M | |||
| Earnings Per Share | 0.28 X | |||
| Number Of Employees | 233 | |||
| Beta | 0.94 | |||
| Market Capitalization | 833.72 M | |||
| Total Asset | 3.98 B | |||
| Z Score | 16.8 | |||
| Net Asset | 3.98 B |
About Surgical Science Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Surgical Science Sweden's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Surgical Science using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Surgical Science Sweden based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Surgical Pink Sheet
Surgical Science financial ratios help investors to determine whether Surgical Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Surgical with respect to the benefits of owning Surgical Science security.